Two-color Flow Cytometry with a CD19 Gate for the Evaluation of Bone Marrow Involvement of B-cell Lymphoma
Authors:
- Chizuru Kawano-YamamotoCKChizuru Kawano-Yamamoto
- Kazuo MuroiKMKazuo Muroi
- Thoru IzumiTIThoru Izumi
- Ken SaitoKSKen Saito
- Keiya OzawaKOKeiya Ozawa
- 1 January 2002
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 43 (11) , 2133-2137
Abstract
The usefulness of two-color flow cytometry with a CD19 gate (CD19-FCM) for detecting clonal B-cells in the bone marrow was evaluated. Since kappa and lambda ratios analyzed in the bone marrow from healthy adults were within the range of 0.5-3.0, outside of this range was regarded as the existence of clonal B-cells. Mixing experiments in vitro showed that 10% or more of clonal B-cells contaminating normal bone marrow cells could be detected using CD19-FCM. Ninety-nine bone marrow samples from 60 patients with B-cell lymphoma were simultaneously analyzed using CD19-FCM and histologic examination of both bone marrow aspiration and core needle biopsy samples. The agreement of results obtained by both examinations was 82% (81/99). Discrepant results were found in 18 samples of 10 patients. All except one sample were positive for CD19-FCM analysis but negative for histologic examination and the conversion of CD19-FCM-positivity to CD19-FCM-negativity was associated with chemotherapy. These results suggest that CD19-FCM is useful for the evaluation of bone marrow involvement of B-cell lymphoma.Keywords
This publication has 9 references indexed in Scilit:
- Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometryCancer, 2000
- Immunophenotypic Analysis of Peripheral Blood and Bone Marrow in the Staging of B-Cell Malignant LymphomaBlood, 1999
- Occult B cell malignancies can be detected by three-color flow cytometry in patients with cytopeniasLeukemia, 1998
- Bone marrow staging in patients with non-hodgkin's lymphomaCancer, 1998
- Fine needle aspiration cytology in the investigation on non-Hodgkin's lymphoma.Journal of Clinical Pathology, 1998
- CD19 Antigen in Leukemia and Lymphoma Diagnosis and ImmunotherapyLeukemia & Lymphoma, 1995
- Diagnostic value of clonality of surface immunoglobulin light and heavy chains in malignant lymphoproliferative disordersAmerican Journal of Hematology, 1993
- Immunophenotypic evaluation of the Bone Marrow in non-Hodgkin's lymphomaHuman Pathology, 1993
- National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usageCancer, 1982